This review highlights the emerging psychiatric effects of GLP‐1 RAs, emphasizing their potential relevance for mood disorders, cognitive dysfunction, and addiction‐related symptoms in individuals with comorbid metabolic conditions. This evidence concerns the gene GCG and mood disorder.